tiprankstipranks
Trending News
More News >
Paltac Corporation (JP:8283)
:8283

Paltac (8283) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Paltac

(OTC:8283)

Rating:73Outperform
Price Target:
¥4,507.00
▲(11.64%Upside)
Paltac's strong financial performance, characterized by low leverage, high equity, and efficient cash management, is a key strength. The valuation is attractive with a reasonable P/E ratio and solid dividend yield. However, technical analysis is mixed, indicating some uncertainty in stock momentum. Overall, Paltac is well-positioned within its industry, offering a balanced investment opportunity with solid financials, though technical indicators suggest caution.

Paltac (8283) vs. iShares MSCI Japan ETF (EWJ)

Paltac Business Overview & Revenue Model

Company DescriptionPaltac Corporation is a leading wholesale distributor in Japan, specializing in the distribution of consumer goods, including cosmetics, daily necessities, and over-the-counter (OTC) pharmaceuticals. The company operates within the retail and wholesale sectors, providing an essential link between manufacturers and retailers by delivering a wide range of products to supermarkets, drugstores, and convenience stores across Japan.
How the Company Makes MoneyPaltac makes money primarily through its wholesale distribution services. The company's revenue model is centered around purchasing consumer goods from manufacturers at a wholesale price and selling them to retailers at a marked-up price. This margin between wholesale and retail pricing constitutes the bulk of Paltac's revenue. Additionally, Paltac benefits from strong relationships and partnerships with both manufacturers and retail chains, enabling efficient supply chain management and fostering long-term business collaborations. The company's extensive logistics network and warehousing capabilities further enhance its ability to deliver products efficiently, contributing to its earnings.

Paltac Financial Statement Overview

Summary
Paltac exhibits strong financial health across all verticals. The income statement reflects consistent revenue and profit growth, supported by stable margins. The balance sheet is characterized by low leverage and high equity, indicating financial stability. Cash flow analysis shows efficient cash generation and management. The overall financial position is solid, with a well-balanced growth trajectory and low financial risk, positioning Paltac well in the Household & Personal Products industry.
Income Statement
82
Very Positive
Paltac has demonstrated strong revenue growth over the recent years with a notable revenue growth rate of 3.14% in the latest year. The gross profit margin remains stable around 7.15%, while the net profit margin has improved to 1.92%. The company's EBIT and EBITDA margins, at 2.52% and 3.30% respectively, indicate efficient operational management. Overall, the income statement reflects robust financial health with consistent growth and improving profitability.
Balance Sheet
78
Positive
The balance sheet of Paltac shows a strong equity position with a debt-to-equity ratio of 0.0012, suggesting low leverage and financial stability. The return on equity stands at 7.95%, highlighting efficient use of equity to generate profits. The equity ratio is healthy at 56.73%, indicating that a substantial portion of the company's assets are financed by shareholders' equity. These metrics illustrate a solid financial footing and low financial risk.
Cash Flow
85
Very Positive
Paltac's cash flow statements reveal a positive trend with a free cash flow growth rate of -8.18% due to temporary fluctuations in capital expenditures. The operating cash flow to net income ratio is 0.90, indicating strong cash generation relative to net income. The free cash flow to net income ratio of 0.84 further emphasizes efficient cash management. Overall, the cash flow position is robust, with consistent generation of free cash flow and effective capital allocation.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue1.19T1.15T1.10T1.05T1.03T
Gross Profit84.92B82.11B82.40B81.76B81.16B
EBITDA39.16B35.92B33.56B33.85B33.65B
Net Income22.86B20.64B19.25B19.64B19.32B
Balance Sheet
Total Assets507.05B495.70B476.94B448.88B435.50B
Cash, Cash Equivalents and Short-Term Investments69.92B60.99B45.99B40.67B37.62B
Total Debt349.00M252.00M244.00M315.00M563.00M
Total Liabilities219.38B217.74B217.24B205.14B200.08B
Stockholders Equity287.67B277.96B259.69B243.74B235.42B
Cash Flow
Free Cash Flow19.27B20.99B10.82B12.54B22.27B
Operating Cash Flow20.68B26.79B16.59B21.95B28.75B
Investing Cash Flow-428.00M-6.27B-6.09B-10.17B-5.47B
Financing Cash Flow-11.32B-5.52B-5.18B-8.73B-8.22B

Paltac Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4037.00
Price Trends
50DMA
4049.50
Negative
100DMA
3994.75
Positive
200DMA
4121.56
Negative
Market Momentum
MACD
-7.29
Positive
RSI
49.66
Neutral
STOCH
61.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8283, the sentiment is Positive. The current price of 4037 is above the 20-day moving average (MA) of 4034.85, below the 50-day MA of 4049.50, and below the 200-day MA of 4121.56, indicating a neutral trend. The MACD of -7.29 indicates Positive momentum. The RSI at 49.66 is Neutral, neither overbought nor oversold. The STOCH value of 61.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8283.

Paltac Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥251.48B11.027.98%2.72%3.14%11.57%
69
Neutral
$480.22B15.2012.05%1.93%13.95%0.37%
68
Neutral
¥197.40B21.118.29%2.33%4.99%3.05%
66
Neutral
$279.63B37.444.49%3.32%-0.74%-25.66%
64
Neutral
$336.37B57.422.08%2.37%4.63%-60.17%
59
Neutral
$398.82B18.747.58%2.04%2.30%33.87%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:8283
Paltac
4,037.00
-103.54
-2.50%
JP:4527
Rohto Pharmaceutical Co
2,068.50
-1,204.23
-36.80%
JP:4927
Pola Orbis Holdings
1,264.00
-26.29
-2.04%
JP:4922
Kose
5,896.00
-3,931.26
-40.00%
JP:4912
Lion
1,469.50
218.20
17.44%

Paltac Corporate Events

PALTAC Emphasizes Independence and Governance in Parent Company Relationship
Jun 20, 2025

PALTAC CORPORATION has announced its relationship with its parent company, MEDIPAL HOLDINGS CORPORATION, emphasizing its independence in business operations and governance. The company has implemented measures to protect minority shareholders and ensure fair transactions with its controlling shareholder, maintaining a balance between autonomy and group governance.

Paltac Corporation Announces Steady Financial Growth for FY 2025
May 26, 2025

Paltac Corporation reported its financial results for the fiscal year ending March 31, 2025, showing a modest increase in net sales and profits compared to the previous year. The company experienced a 3.1% rise in net sales to ¥1,188,097 million and a 10.8% increase in profit to ¥22,864 million. The financial position remains stable with a slight increase in total assets and net assets, and a higher dividend payout is planned for the next fiscal year. These results indicate a steady growth trajectory and a commitment to returning value to shareholders.

Paltac Corporation Reports Strong Fiscal Year Performance with Increased Profits and Dividends
May 12, 2025

Paltac Corporation reported a 3.1% increase in net sales and a 10.8% rise in profit for the fiscal year ending March 31, 2025, indicating strong operational performance. The company also announced a higher annual dividend, reflecting confidence in its financial health and commitment to shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 05, 2025